| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 1.1 | 0.0001 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.99 | 0.0001 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.004 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 27 | 0.005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.78 | 0.008 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |